tiprankstipranks
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market
RDY
Dr Reddy's Laboratories
RESEARCH TOOLSreports
Want to see RDY full AI Analyst Report?

Dr Reddy's Laboratories (RDY) Financial Statements

454 Followers

Dr Reddy's Laboratories Financial Overview

Dr Reddy's Laboratories's market cap is currently $11.62B. The company's EPS TTM is $51.52; its P/E ratio is 23.89; and it has a dividend yield of 0.64%. Dr Reddy's Laboratories is scheduled to report earnings on May 12, 2026, and the estimated EPS forecast is $0.10. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 353.47B₹ 325.54B₹ 279.16B₹ 245.88B₹ 214.39B
Gross Profit₹ 186.52B₹ 190.43B₹ 163.61B₹ 139.34B₹ 113.84B
Operating Income₹ 48.87B₹ 71.84B₹ 67.73B₹ 57.14B₹ 29.48B
EBITDA₹ 70.55B₹ 96.67B₹ 88.42B₹ 74.43B₹ 45.08B
Net Income₹ 45.09B₹ 56.54B₹ 55.68B₹ 45.07B₹ 23.57B
Balance Sheet
Cash & Short-Term Investments₹ 86.08B₹ 57.91B₹ 81.47B₹ 61.80B₹ 44.37B
Total Assets₹ 567.88B₹ 492.99B₹ 387.52B₹ 321.85B₹ 292.83B
Total Debt₹ 75.81B₹ 46.77B₹ 20.02B₹ 13.47B₹ 33.84B
Net Debt₹ 60.75B₹ 32.11B₹ 12.91B₹ 7.69B₹ 18.99B
Total Liabilities₹ 194.95B₹ 155.82B₹ 106.97B₹ 90.86B₹ 102.30B
Stockholders' Equity₹ 369.60B₹ 333.39B₹ 280.55B₹ 230.99B₹ 190.53B
Cash Flow
Free Cash Flow₹ 32.10B₹ 12.03B₹ 18.00B₹ 40.01B₹ 9.06B
Operating Cash Flow₹ 56.65B₹ 46.43B₹ 45.43B₹ 58.88B₹ 28.11B
Investing Cash Flow₹ -70.53B₹ -58.08B₹ -40.28B₹ -41.37B₹ -26.39B
Financing Cash Flow₹ 13.40B₹ 18.91B₹ -3.76B₹ -26.86B₹ -2.42B
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Income Statement >

Dr Reddy's Laboratories Debt to Assets

Balance Sheet >

Dr Reddy's Laboratories Cash Flow

Cash Flow >

Dr Reddy's Laboratories Forecast EPS vs Actual EPS

Earnings >